Jens Lohr, MD from Dana-Farber Cancer Institute discusses limitations of blood biopsy and that one must have enough circulating DNA in the bloodstream at the 2017 American Society of Hematology.
Jens Lohr, MD from Dana-Farber Cancer Institute discusses limitations of blood biopsy and that one must have enough circulating DNA in the bloodstream at the 2017 American Society of Hematology.